Clinical trial
Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia
NCT00260338 · Rigshospitalet, Denmark, Other · Completed
Key facts
| NCT number | NCT00260338 |
|---|---|
| Title | Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia |
| Official title | Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia |
| Lead sponsor | Rigshospitalet, Denmark, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia, Coronary Heart Disease |
| Intervention type | Biological |
| Interventions | stem cell |
| Enrollment | 31 |
| Start date | Dec 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Dec 1, 2005 |
| Last update posted | May 31, 2013 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: